Visalytics
Visalytics
approved EB-2 (NIW)

Research Specialist

Cancer Biology · India · 2025-04-30

Processing Time
380 days
Decision Date
2025-04-30
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in cancer biology, specifically focusing on the development of gene therapy and immunotherapy. This work involves creating novel non-invasive monitoring methods to improve treatment effectiveness while reducing patient discomfort. The endeavor aims to advance precise cancer treatments and improve public health outcomes in the United States.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the nationally important goal of improving cancer care and patient outcomes through non-invasive monitoring and advanced therapies.

2 Well-positioned to Advance the Endeavor Met

The petitioner's expertise is evidenced by a strong publication record, high citation percentiles, and 18 peer reviews for professional journals.

3 Balance of Interests Met

It was determined that the U.S. benefits from waiving the labor certification due to the petitioner's unique contributions to biomedical research and public health.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles, 1 preprint, and 1 conference abstract, which garnered 63 citations. Two of these publications ranked in the top 10% of cited works in Biology & Biochemistry, and the petitioner completed 18 peer reviews for authoritative journals. The case was supported by two expert letters and demonstrated alignment with national goals for improving cancer care, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 380 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist